InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Newton Charles W.. Director active across 2 companies, notably Lyell Immunopharma, Inc.. Aggregated, 6 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €103k. History available since 9 February 2024. The latest transaction was disclosed on 17 March 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
6 of 6 declarations